PT Clinical Trials

• Gas Supply, Demand and Middle Ear Gas Balance: Sp Aim 3a Pt ii
  ClinicalTrials.gov Identifier: NCT00494364 - Recruiting
  Healthy
  
• Study of Talabostat and Rituximab in Advanced Chronic Lymphocytic Leukemia (CLL)
  ClinicalTrials.gov Identifier: NCT00086203 - Active, not recruiting
  Chronic Lymphocytic Leukemia
  
• ARIA(Atacand Renoprotection In NephropAthy Pt.)
  ClinicalTrials.gov Identifier: NCT00573430 - Not yet recruiting
  Non-Diabetic Nephropathy With Hypertension
  
• Safety Study of PT-523 in Cancer Patients to Treat Solid Tumors Including a Preliminary Assessment of Effectiveness
  ClinicalTrials.gov Identifier: NCT00088023 - Terminated
  Neoplasms
  
• A Study to Evaluate PT-523 in Patients with Refractory Leukemia
  ClinicalTrials.gov Identifier: NCT00129558 - Suspended
  Leukemia
  
• Retrospective Chart Review of Pt. Who Have Had an Open, Laparoscopic, Ureteroscopic or Percutaneous Surgery
  ClinicalTrials.gov Identifier: NCT00395564 - Recruiting
  Review de-Identified Data of Pts Who Have Had Open, Laparoscopic, Ureteroscopic or Percutaneous Urologic Surgery at UCIMC
  
• A Study to Evaluate PT-523 in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
  ClinicalTrials.gov Identifier: NCT00112060 - Suspended
  Non-Small-Cell Lung Carcinoma
  
• Study of Talabostat in Advanced Melanoma
  ClinicalTrials.gov Identifier: NCT00083239 - Completed
  Melanoma; Skin Cancer
  
• Study of Talabostat and Docetaxel in Advanced Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00080080 - Completed
  Lung Cancer
  
• Study of Talabostat and Cisplatin in Advanced Melanoma
  ClinicalTrials.gov Identifier: NCT00083252 - Completed
  Melanoma; Skin Cancer